Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Gay F, Cerrato C, Petrucci MT. et al.
Efficacy of carfilzomib lenalidomide dexamethasone (KRd) with or without transplantation in newly diagnosed myeloma according to risk status: Results from the FORTE trial.

J Clin Oncol 2019;
37 (15) 8002-8002

Bibliographische Angaben herunterladen

Aufrufen in: